RT Journal Article
SR Electronic
T1 Psoriatic Arthritis Management Update – Biotherapeutic Options
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 65
OP 68
DO 10.3899/jrheum.090229
VO 83
A1 TAJVUR P. SABER
A1 DOUGLAS J. VEALE
YR 2009
UL http://www.jrheum.org/content/83/65.abstract
AB Psoriatic arthritis (PsA) is a seronegative spondyloarthropathy (SpA) occurring in up to 30% of patients with psoriasis. It has a wide variation of annual incidence (median 6.4, range 0.1–3.1 per 105 people), based on analysis of 13 incidence and prevalence reviews published between 1987 and December 2006. Conventional treatments with antiinflammatory and disease modifying or antirheumatic drugs are not efficacious in all patients, in particular those with axial disease. This review examines new pharmacological developments in the treatment of PsA with a focus on biologic therapies.